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Abstract A disposable PCR-based amperometric magneto-genosensor for 27 
detection and identification of Streptococcus pneumoniae was evaluated. ROC 28 
curve analysis used to determine optimal signal cutoff values yielded a 29 
sensitivity of 91 % and a specificity of 90 %. The method was also tested for the 30 
direct detection of pneumococci in clinical samples.  31 
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The streptococci of the Mitis group (SMG) include the closely related species 49 
Streptococcus pneumoniae, Streptococcus mitis, Streptococcus 50 
pseudopneumoniae and Streptococcus oralis, which possess significantly 51 
different pathogenic properties and antimicrobial susceptibility patterns. 52 
Differentiation between pneumococci and other SMG is clinically relevant and is 53 
typically done by phenotypic (e.g., optochin susceptibility testing and/or bile 54 
solubility assay) and/or serological methods (Lund and Henrichsen, 1978). The 55 
methods that require bacterial culturing are time-consuming, while 56 
immunochromatographic methods are rapid but present cross-reactivity 57 
problems in some patient groups (Blaschke, 2011).  58 
To improve accuracy and speed diagnosis, new methods based on the 59 
polymerase chain reaction (PCR) have been developed (Harris et al., 2008; 60 
Rouphael et al., 2008; Sheppard, 2004; Smith et al., 2009). Several S. 61 
pneumoniae-specific markers have been proposed among which the most 62 
relevant are the ply and lytA genes, which encode the pneumolysin (Marriott et 63 
al., 2008) and the main autolysin (López and García, 2004), respectively.  64 
Homologs of the lytA gene of S. pneumoniae have also been found in other 65 
SMG but characteristic features in the pneumococcal gene have allowed the 66 
design of a specific PCR assay (Llull et al., 2006; Obregón et al., 2002).  67 
Electrochemical DNA biosensors, also called genosensors, are based on the 68 
integration of a sequence-specific probe and an electrochemical signal 69 
transducer, and offer an interesting detection method (Drummond et al., 2003; 70 
Lucarelli et al., 2008) which is easy to implement, with low instrumentation 71 
costs, and the possibility for accurate and sensitive detection in small sample 72 
volumes (Wei et al., 2010).  73 
Magnetic beads (MBs) facilitate efficient target retrieval and concentration, 74 
reduce the assay time and favor higher sample throughput and automation 75 
(Chen et al., 2007). The use of MBs enhances sensitivity and reduces detection 76 
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 4 
time in electrochemical genosensors (Bettazzi et al., 2013; Campuzano et al., 77 
2011; Pedrero et al., 2012).  78 
We present an evaluation of the performance of a recently described 79 
amperometric magneto-genosensor for the identification of S. pneumoniae 80 
(Campuzano et al., 2011) using a collection of microbial isolates and clinical 81 
samples in comparison with standard microbiological identification procedures. 82 
The sensor uses a specific DNA capture probe for the detection of a 83 
characteristic lytA single-stranded DNA fragment amplified by asymmetric PCR 84 
(aPCR) (Fig. 1). Both, the capture probe and the single-stranded amplicon are 85 
biotinylated. Streptavidin-modified MBs are loaded with the capture probe, the 86 
loaded beads are then hybridized with the aPCR product, and the hybrid 87 
molecules are labeled with streptavidin-peroxidase polymer (Strep-HRP). The 88 
modified MBs are captured by a magnetic field on the surface of 89 
tetrathiafulvalene (TTF)-modified gold screen-printed electrodes (Au/SPEs) and 90 
the peroxidase activity is measured as the amperometric response at –0.15 V 91 
upon H2O2 addition. 92 
Microbial isolates (n = 107) were identified by Vitek 2 (BioMérieux SA, Marcy 93 
l’Etoile, France) or Wider systems (Francisco Soria Melguizo SA, Madrid, 94 
Spain), MALDI-TOF mass spectrometry (Bruker Daltonics, GmbH, Bremen, 95 
Germany) and optochin test. 96 
Clinical samples (n = 109) were obtained from skin, abscesses, sputum, 97 
purulence, blood, swabs taken from throat, ear or conjunctiva, nasal, tracheal or 98 
bronchial aspirates, pleural fluid and bronchoalveolar washes. All the samples 99 
were obtained in the Microbiology Department of Hospital La Paz, and had 100 
been anonymized previously, keeping only microbiological data. 101 
DNA (from agar plate cultures or from clinical samples) was extracted using 102 
the UltraClean® Microbial DNA Isolation Kit (MoBio, Carlsbad, CA USA). When 103 
required, clinical samples were fluidised with 0.7% dithiothreitol (final 104 
concentration) before extracting DNA. 105 
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 5 
The magneto-genosensing strategy has been recently described 106 
(Campuzano et al., 2011). Briefly, streptavidin-coated MBs were loaded with the 107 
biotinylated DNA capture probe and hybridized with the amplicon generated by 108 
aPCR (biotinylated reverse to forward primer ratio of 8:1). The hybrid-attached 109 
beads were washed twice with 500 μL of Tris–HCl (pH 7.2) and labeled with  110 
streptavidin-peroxidase polymer. The enzyme-tagged hybrid-MBs assemblies 111 
were washed five times (2 min each) with 500 μL of PBST (PBS containing 112 
0.05% Tween®20), and once more with 500 μL of PBS (10 mM sodium 113 
phosphate buffer solution containing 137 mM NaCl and 2.7 mM KCl, pH 7.5). 114 
The MBs were resuspended in 45 μL of PBS and magnetically captured on the 115 
surface of gold screen-printed electrodes (220AT, 4-mm , Dropsens, Spain) 116 
by placing a neodymium magnet under the working electrode surface. TMB-117 
H2O2 K-Blue reagent solution (Neogen, Lexington, KY) in a ready-to-use format 118 
(K-Blue enhanced-activity substrate, also containing H2O2) was used as 119 
substrate, and amperometric measurements were done with a single-channel 120 
amperometric detector (InBea Biosensores S. L., Madrid, Spain). Statistical 121 
analyses were done using SPSS 17.0. The continuous output obtained from 122 
amperometric measurements was transformed into a binary classification by 123 
ROC curve analysis. The optimal cutpoint value was determined as the point on 124 
the ROC curve closest to (0.1) and the Youden index (Perkins and 125 
Schisterman, 2006), which maximize sensitivity and specificity. 126 
Genosensor performance was tested with a series of 107 cultured microbes 127 
obtained from clinical samples. Seventy nine had been classified as S. 128 
pneumoniae (Sp) and twenty eight were non-pneumococcal isolates 129 
(designated as N-Sp): 25 streptococci [Streptococcus anginosus (2 strains), 130 
Streptococcus gallolyticus (1 strain), Streptococcus intermedius (3 strains),  S. 131 
mitis (8 strains), S. oralis (4 strains), Streptococcus pyogenes (4 strains), 132 
Streptococcus salivarius (1 strain), Streptococcus sanguinis (1 strain) and 133 
Streptococcus suis (1 strain)], and three non-streptococcal microbes, i.e., 134 
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 6 
Staphylococcus lugdunensis, Enterococcus faecalis and Candida albicans. All 135 
the samples were tested in duplicate. Two blanks were included in each PCR 136 
run to control reagent contamination and were also processed to determine the 137 
baseline of the amperometric measurements. Typically, the blanks (n = 102) 138 
gave signals around –100 nA. To minimize inter-assay variation the sample 139 
signals were normalized dividing them by their corresponding blanks. The 140 
average of the normalized ratios was 7.55 for Sp isolates and 1.15 for N-Sp 141 
species (Fig. 2A). An optimal cutoff value of 1.92 for the sample to blank ratio 142 
was estimated from ROC curve analysis (Fig. 2C). The same value was 143 
obtained with the ROC (0.1) and the Youden indexes. The area under the curve 144 
(AUC) was 0.94 [95 % confidence interval (CI) 0.89–0.98]. Using a normalized 145 
value >1.92 as the threshold to identify S. pneumoniae, 73 out of 79 146 
neumococci and 25 out of 28 non-neumococci were correctly identified. With 147 
this cutoff, the assay had a sensitivity of 91 % (95 % CI 85–97 %) and a 148 
specificity of 90 % (95 % CI 79–100 %) (Table I). The seven false negative and 149 
the three false positive (two S. mitis and one S. pyogenes) results were tested 150 
and their identity was confirmed by lytA PCR and 16S rRNA gene 151 
pyrosequencing (data not shown). 152 
The ability of the method to directly detect S. pneumoniae in complex clinical 153 
samples was tested. A series of 109 samples of diverse origins that had been 154 
previously used for microbiological diagnostic were collected (Table II and Fig. 155 
2B). Total DNA was extracted and a fixed volume (5 L) was used for aPCR of 156 
the lytA gene. S. pneumoniae had been identified in 60 samples. In 44 of them, 157 
the genosensor gave a positive identification, while in 16 the results were 158 
negative. The remaining 49 samples included 7 samples in which no growth 159 
was detected, 13 samples containing mixed saprophytic microbiota, and 29 160 
samples in which some other pathogen had been identified (including several 161 
streptococci and staphylococci, Pseudomonas sp., Acinetobacter baumannii, E. 162 
coli, Enterobacter cloacae, Haemophilus influenzae, Moraxella catarrhalis, 163 
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 7 
Stenotrophomonas maltophilia, Candida parapsilosis and C. albicans).  In 39 of 164 
these 49 samples the genosensor results were negative (≤1,92), while 10 165 
samples were positive. Five of these were polymicrobial and four were sterile.  166 
With the cutoff selected, both sensitivity and specificity were around 90 %. 167 
PCR retesting and 16S gene pyrosequencing of conflicting samples suggested 168 
that the source of variability is the processing of amplicons (including binding to 169 
MBs, washing of loaded MBs and their magnetic capture on the working 170 
electrode surface) for amperometric measurement, rather than the PCR or the 171 
amperometric measurement itself. Along this line, ongoing work on automation 172 
of magnetogenosensor preparation is directed to reduce processing time and 173 
inter-assay variability.  174 
Evaluation of the genosensor with a set of clinical samples showed its 175 
feasibility for the direct detection of pneumococci in a wide variety of samples 176 
ranging from blood, pleural fluids to conjunctival swabs. The false negatives 177 
found and the fact that about half of them had amperometric ratios near the 178 
cutoff point suggests that detection might be improved using specific cutoff 179 
points for the different sample types. The positive results found in some sterile 180 
samples suggests that the genosensor might be detecting DNA from dead 181 
bacteria. 182 
The use of disposable sensors and commercial MBs makes magneto-183 
biosensing platforms an interesting approach for the detection of pathogens, 184 
which can be integrated into portable, multiplexed and automatic devices 185 
without requiring special human or material resources.  186 
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 269 
 270 
Fig. 1. Scheme of the amperometric detection of the pneumococcal lytA gene: 271 
magnetic beads (MBs) are loaded with capture probe and this is hybridized with 272 
lytA single-stranded aPCR product which is then labeled with streptavidin-HRP. 273 
MBs are captured by a magnetic field over the surface of a TTF-Au/SPE 274 
electrode. To determine the amount of aPCR product the peroxidase activity 275 
over the electrode is measured by amperometric detection of the reduction of 276 
H2O2 with TTF. 277 
278 
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 301 
Fig. 2 Boxplot of normalized amperometric values obtained with 107 microbial 302 
isolates (A) or 109 clinical samples (B). The line within the boxes indicates 303 
the median, the boxes span the interquartile range. (C) ROC curve of the 304 
signal-to-blank ratio obtained with the magneto-amperometric genosensor 305 
for microbial isolates (AUC = 0.94). 306 
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Table I Genosensor assay results obtained with DNA purified from 308 
cultured microbial isolatesa 309 
 310 
  Microbiological identification  
  Sp N-Sp Total 
Magneto-genosensor 
results 
Sp 72 3 75 
N-Sp 7 25 32 
 Total 79 28 107 
a Sp, Streptococcus pneumoniae; N-Sp, non-pneumococcal microorganisms. 311 
 312 
313 
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Table II Genosensor assay results obtained with total DNA purified directly 314 
from clinical samples 315 
 316 
 
Streptococcus 
pneumoniae 
Others 
  GS+ GS– GS+ GS– 
Abscess 1  1** 3 
BAL 2   2 
BAS 10 6 1* 14 
Bilis   1**  
Blood 1    
Conjuctival 
swab 9 1   
Nasal aspirate 3 1 2** 2 
Otical 4 2 1  
Pleural Fluid 1  1* 2 
Skin    2 
Sputum 12 6 1** 8 
Tissue    1 
Tracheal 
aspirate 1  1* 4 
Urine   1*  
Wound       1 
 44 16 10 39 
 317 
* sterile samples; ** polymicrobial samples 318 
 319 
 320 
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